Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" has been ...
—New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug development— SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held ...
The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of ...
A booming biologics market is increasing demand for specialist fill-finish services and prompting contractors to invest in technologies that reduce waste and safeguard these sensitive medicines. The ...
DUBLIN--(BUSINESS WIRE)--The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" report has been added to ...
SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis ...
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results